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Abstract
Objectives: Studies have shown that human and peripheral blood mononuclear cells (PBMCs) 
are mostly used for research purposes to study several biochemical endpoints. The effects of the 
flavonoids, genistein, kaempferol, and quercetin on phospho tensin homolog (PTEN) levels in 
cancer cells (i.e., breast [BT549], lung [A549]), human embryonic kidney cells (HEK293), and the 
levels of lipid peroxides (LP) in PBMCs were respectively investigated.
Materials and methods: Cancer, kidney, and PBMCs from several donors were each exposed 
to each of the flavonoids at concentrations of 0, 5, 10, 15, 20, and 25 μM. Our hypotheses were 
that exposure of cancer and kidney cells to genistein, kaempferol, and quercetin can increase 
PTEN and decrease lipid peroxides in PBMCs levels respectively to better cope with oxidative 
stress.
Results: The results indicate that the flavonoids increased total PTEN levels in a dose-dependent 
manner. The effect of quercetin was more pronounced followed by genistein and kaempferol. 
Furthermore, decreases in lipid peroxides were observed in the PBMCs for the flavonoid-treated 
samples compared to those exposed to flavonoids and with oxidative stress as described by 
Fenton’s chemistry. Levels of LP in quercetin-treated samples were lower compared to kaempferol 
and genistein.
Conclusions: The findings suggest that the flavonoids play an important role in controlling 
oxidative stress in several human cells.
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Phosphatase and tensin homolog (PTEN) was discovered in 1997 independently by three 
laboratories as a tumor suppressor of which the expression is often lost in tumors (1–3). 
Later studies established that PTEN is a negative regulator of a major cell growth and 
survival signaling pathway, namely the phosphatidylinositol-3-kinase (PI3K)/Akt signaling 
pathway (1, 2). The biological effects of PTEN, however, are dominated by its ability to 
dephosphorylate the lipid substrate phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P3) 
whereas protein substrates for PTEN are being discovered (4). PI-3,4,5-P3 is formed when 
PI3K is stimulated as a result of growth factors binding to their receptors that are coupled to 
PI3K (3). The enzymatic function of PTEN thus reduces the cellular concentration of 
PI-3,4,5-P3 and acts as a negative regulatory signaling for the PI3K mitogenic signaling 
pathway (3). Accumulation of PI-3,4,5-P3 serves as a major signal for growth factor 
accumulation where PI-3,4,5-P3 binds to the pleckstrin homology (PH) domain of 
downstream proteins (e.g., Akt) and provides a lipid moiety for these proteins to bind to the 
lipid membranes (4). Binding of PI-3,4,5-P3 to the PH domain also changes the confirmation 
of these proteins so they can later be activated by phosphorylation. By reducing the 
intracellular levels of PI-3,4,5-P3, PTEN inhibits the activation of downstream proteins of 
the PI3K pathway, including the serine/threonine kinase Akt and the protein kinase C (3). It 
has also been reported that activation of hPPARγ causes an increase in PTEN protein levels 
or a decrease in transforming growth factor β1 levels, resulting in tumor suppression through 
induction of apoptosis, inhibition of cellular growth, and/or promotion of cellular 
differentiation of cancer cells (5–7).
Peripheral blood mononuclear cells (PBMCs) generally refer to monocytes and 
lymphocytes, representing cells of the innate and adaptive immune systems. PBMCs are a 
promising target tissue in the field of nutrigenomics because they seem to reflect the effects 
of dietary modifications at the level of gene expression (8). Current studies have 
demonstrated that PBMCs seem to reflect liver environment and complement adipose tissue 
findings in transcriptomics (8). The main function of the immune system is to prevent or 
limit infections by microorganisms such as bacteria, viruses, fungi, and parasites. Immune 
responses are mediated by lymphocytes (white blood cells [WBCs], which derive from 
precursors in the bone marrow and then migrate to guard peripheral tissues (9). For example, 
WBCs are cells of the adaptive immune system, which recognize specific pathogens and act 
by protecting against recurrent infections and are the largest cell population covered by the 
more general term PBMCs, which also include monocytes (9). PBMCs seem to reflect 
hepatic regulation of cholesterol metabolism (10) and can migrate through the blood 
circulation and infiltrate various tissues such as the endothelium and adipose tissue (11). 
Since PBMCs can also reflect the responses of dietary modifications and drugs at the level 
of gene expression (12, 13), they have also been a subject of great interest in clinical and 
intervention studies for transcriptomics profiling (8). Furthermore, PBMCs are convenient 
because they can be easily and repeatedly collected in sufficient quantities, in contrast to 
adipose, muscle, and liver tissues. However, PBMC transcriptomics from dietary 
intervention studies have not resulted yet in clear confirmation of candidate genes related to 
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disease risk. Use of microarray technology in larger well-designed dietary intervention 
studies are still needed for exploring PBMCs’ potential in the field of nutrigenomics (8).
In our recent studies on the effects of quercetin, kaempferol, and exogenous glutathione on 
phospho- and total-Akt in 3T3-L1 preadipocytes we observed significant decreases in 
phospho-Akt levels in cells treated each with either quercetin, kaempferol, or reduced 
Glutathione (GSH) at several doses compared to their respective controls (14). As described 
in the above studies (14), 3T3-L1 preadipocytes, exposed to quercetin, kaempferol, and GSH 
respectively blocked the activation of Akt, suggesting the importance of quercetin, 
kaempferol and GSH in preadipocytes cell differentiation (14). In view of those findings, it 
became obvious and plausible to hypothesize that the decreases in Akt following exposure to 
the flavonoids may indicate a direct increase on the expression levels of PTEN in cells. 
Furthermore, PBMC gene expression after dietary intervention studies can be used for 
studying the response of certain genes related to fatty acid and cholesterol metabolism and 
to explore the response of dietary interventions in relation to inflammation. Thus, the 
purpose of the present study was to further investigate the effects of exposure of several 
doses each of genistein, kaempferol, and quercetin (i.e., 0, 5, 10, 15, 20, and 25 μM doses) 
on the levels of PTEN in two cancer cell lines, namely, breast (BT549) and lung (A549) and 
human embryonic kidney cells (HEK293). Second, we sought to study the effects of the 
flavonoids on lipid peroxides in PBMCs before and following exposure to oxidative stress 
through the Fenton’s chemistry. Our study will test two hypotheses: (1) Exposure of cancer 
cells to either genistein, kaempferol, or quercetin can increase PTEN levels in those cells 
and to better cope with oxidative stress. (2) The flavonoids might help individuals better 
cope with oxidative damage through the inflammatory processes by PBMCs cells by 
decreasing the levels of lipid peroxides. The proposed studies represent an effort to define 
how genistein, kaempferol, and quercetin modulate the expression levels of PTEN, a tumor 
suppressor gene, in lung, breast, and kidney cells as wells the levels of oxidation in PBMC 




Isoflavone kaempferol (3,5,7-trihydroxy-2-(4-hydroxy-phenyl)-4H-chromen-4-one) and 
genistein (4′,5,7-trihydroxy isoflavone) and quercetin dihydrate (3,3′,4′,5,7-
Pentahydroxyflavone dihydrate) were from Sigma-Aldrich (St. Louis, MO). Disodium 
Ethylenediaminetetraacetic acid (EDTA), ferrous sulfate (FeSO4), Dulbecco’s Modified 
Eagle’s Medium (DMEM), Roswell Park Memorial Institute (RPMI) media, and hydrogen 
peroxide(H2O2), were purchased from Fisher Scientific Suwanee, GA. Lung (A549), breast 
(BT549), and kidney (HEK293) cancer cell lines were obtained from the American Type 
Culture Collection, Manassas, VA. Blood filters were generously donated by the American 
Red Cross of Nashville, TN. All chemicals were of high purity (>99%), according to the 
manufacturer, and were used without further purification.
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peripheral blood mononuclear cells’ (PBMCs), were isolated from leukocyte filters (Pall 
corporation, Westborough, MA-Reduced red blood cells platelets leukocytes [RCPL]) 
obtained from the Red Cross Blood Bank Facility (Nashville, TN) as described in (15) with 
some modifications. Leukocytes were retrieved from the filters by back-flushing them with 
an elution medium (sterile phosphate buffered saline [PBS] pH 7.4 containing 5 mM 
disodium EDTA and 2.5% [w/v] sucrose) and collecting the eluent. The eluent was layered 
onto Ficoll-Hypaque (1.077 g/mL) and centrifuged at 1200 g for 30–50 minutes. 
Granulocytes and red cells pelleted at the bottom of the tube while the PBMCs floated on 
the Ficoll-Hypaque. Mononuclear cells were collected and washed with PBS (500 × g, 10 
minutes). Following washing, the cells were layered on bovine calf serum for platelet 
removal. The cells were then suspended in RPMI-1640 complete medium which consisted 
of RPMI-1640 supplemented with 10% heat-inactivated bovine calf serum, 2 mM L-
glutamine, and 50 U penicillin G with 50 μg streptomycin/ml. This preparation constituted 
PBMCs.
Culturing of cancer, PBMC cells, and treatment with the flavonoids
BT549, A549, HEK293, and PBMCs were maintained at 37 °C under 5% CO2 atmosphere 
in DMEM containing 4 mM L-glutamine, 4500 mg/L glucose, 1 mM sodium pyruvate, 1500 
mg/L sodium bicarbonate, 10% fetal bovine serum, and 1% penicillin and streptomycin5. At 
80% confluence in T-75 flasks, the cancer cells were trypsinized with 3 ml of trypsin-EDTA 
solution and later subcultured in six-well plates (at 5 × 105 cells/well) before treatments with 
various flavonoids at the doses each of 0, 5, 10, 15, 20, and 25 μM. PBMC cells were also 
seeded in six-well plates (at 1 × 106 cells/well) before treatments with the flavonoids. All the 
cells following the treatments were cultured for 24 hours in the incubator under the same 
conditions as described above.
Cell viability
Cell viability was assessed at the beginning and end of each exposure period. Viability was 
determined using the trypan blue exclusion method. Cells were briefly mixed with trypan 
blue and counted using a hemocytometer. The total number of cells and the total number of 
live cells were determined for both control and treated cells to determine the percentage 
viable cells.
Sample preparation following the treatments with flavonoids
Cancer and human embryonic kidney cells were trypsinized with 1 ml trypsin-EDTA and 
transferred into Eppendorf tubes. Wells were each washed with 330 μl DMEM media and 
transferred into their respective tubes. PBMCs were also removed from the six well plates 
and placed into Eppendorf tubes. The tubes were centrifuged in a refrigerated Eppendorf 
table top centrifuge (Model # 5804 R, Suwanee, GA) at 4 °C for 10 minutes at 3000 RPM. 
For PTEN analysis cells were lysed as described by the Ray Bio® Human/Mouse/Rat 
Phospho-PTEN (S380) and Total PTEN ELISA Kit (Cat.#: PEL-PTEN-S380-T) with the 
following modifications. Cells were rinsed with sterile PBS to remove any remaining 
medium before adding the lysis buffer. They were then solubilized in 1X lysis buffer 
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containing protease and phosphatase inhibitors. Cell lysates were pipetted up and down to 
re-suspend and incubated with shaking at 8 °C for 30 minutes. Lysates were then centrifuged 
at 13,000 RPM for 10 minutes 4 °C, and the supernatants were transferred into clean test 
tubes and stored at −70 °C before use. For the analysis of lipid peroxides (measured as 
malonaldehyde [MDA] levels) PBMCs were sonicated with 100 μL cold PBS on ice using 
the Fisher Sonic Dismembrator (Model#: 100, Suwanee, GA) at a setting of 3 for 20 seconds 
for each sample. Samples were centrifuged as described for the cell lysates and subsequently 
stored at −70 °C before use.
Analysis of PTEN in cancer cell lines
PTEN levels in the cells after the treatments was analyzed as described by the RayBiotech 
Human/Mouse/Rat Total PTEN ELISA Kit (Cat.#: PEL-PTEN-S380-T) with the following 
modifications as described below.
Preparation of positive control
Briefly, 400 μl of the 1x assay diluent was added to the vial containing the lyophilized 
powder (HELACALS001-1 used as positive control) to prepare the serial dilutions. Care was 
taken to make sure that the lyophilized powder was thoroughly dissolved in 400 μl of assay 
diluent by gentle mix to prepare the Positive Control (P-1) to produce a dilution series as 
indicated below. 300 μl of the 1x assay diluent was pipetted into several Eppendorf tubes 
(i.e., P-2, P-3, and P4) and 150 μl from the P-1 solution and the rest of the P-tubes were 
transferred in sequential order to produce a dilution series of P-1, P-2, P-3, and P-4. Care 
was taken to bring all reagents and samples to room temperature (18–25 °C) before use.
Assay procedure
100 μl of each sample or positive control (HELACALS001-1) were added to the appropriate 
96-well plates and covered with the plate holder and incubated overnight at 4 °C with 
shaking. Following the incubation, the solution in the wells was discarded and each well 
washed four times with the 1 × wash solution. Care was taken to remove completely any 
residual liquid to enhance a good performance of the assay by inverting the plate and 
blotting against a clean paper towel. 100 μl of the prepared 1x detection antibody, anti-PTEN 
(S380) or anti-PTEN, was added to the appropriate wells and incubated for 1 hour at room 
temperature with shaking. The liquid in the wells was discarded after the incubation and the 
wells were each washed three times with the wash buffer as described above.
Further, 100 μl of the prepared 1× HRP-conjugated anti-rabbit IgG against anti-PTEN 
(S380) or HRP-conjugated streptavidin were added to the corresponding wells and incubated 
for 1 hour at room temperature with shaking. The solution in the wells was discarded and 
washed three times with the wash buffer as previously described. After the incubation, 100 
μl of the 3,3′,5,5′-tetramethylbenzidine one-step substrate reagent was added to each well 
and incubated at room temperature in the dark with shaking for 30 minutes. Following the 
incubation, 50 μl of the stop solution (i.e., 0.2 M sulfuric acid) [H2SO4]), was added to each 
sample and the samples read in a Synergy 96 well plate reader (Winooski, VT) at 450 nm.
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Analysis of lipid peroxides in PBMCs
MDA was analyzed as prescribed by the Calbiochem lipid peroxidation assay kit (Cat. No. 
437634) with some modifications as described below. Cells were lysed by repetitive 
freezing/thawing in sterile PBS. Then 650 μl of diluted 10.3 mM N-methyl-2-phenylindole, 
in acetonitrile, was added to 200 μl of cell lysate and vortexed for three to four - seconds. To 
assay for MDA only, 150 μl of the 12 N HCl solution instead of the methanesulfonic acid 
was added to the samples, mixed and tightly closed. Samples were incubated at 45 °C for 60 
minutes, cooled on ice and the absorbance measured at 586 nm in the plate reader as 
described above under the assay procedure for PTEN. For controls, a blank sample was 
prepared which contains all the reagents and the sterile PBS. Standard curves for MDA (as 
bis[dimethyl acetal[ in 20 mM Tris-HCl buffer, pH 7.4) was prepared and used for 
calculating the molar extinction coefficient (ε) of the measured product which was equal to 
the slope of the line. The following equation was used to calculate the MDA levels in the 
sample by the equation below:
[MDA] = (A  −  A0)  ×  D/ε
Where: A is the absorbance at 586 nm for the sample A0 is the absorbance of the blank
D is the sample dilution factor (200 μl of a sample in a total volume of 1 ml)
ε is the apparent molar extinction coefficient obtained from the standard curve.
Care was taken to ensure that those cloudy samples or samples containing cellular debris 
were transferred to polypropylene micro tubes and centrifuged at 15,000 × g for 10 minutes 
just prior to measuring the absorbance. The absorbance of the clear supernatant was read at 
586 in a 96-well BioTek Synergi plate reader (Wilnooski, VT). MDA levels in cells were 
corrected for protein and the results expressed as MDA/mg protein.
Statistical analysis
Results are expressed as means ± standard deviation. Statistical significance was determined 
by two-way analysis of variance (ANOVA) followed by student’s t-test, and p < 0.05, was 
considered statistically significant. Each value in all figures represents the mean for each 
dose level of flavonoid and MDA tested, which was assayed in triplicates. PTEN values 
were measured by absorbance level as stated in the manufacturer’s protocol.
Results
Effects of flavonoids on PTEN levels in cancer cell lines
Figures 1 through 3 show the effects of exposure of each of the respective flavonoids, 
genistein, kaempferol, and quercetin, at 0, 5, 10, 15, 20, and 25 μM on PTEN levels in the 
respective cells.
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Effects of the flavonoids on lung cancer cells (A549)
As shown in Figure 1 for A549 cells, PTEN levels seem to increase for each of the 
flavonoids in comparison to their respective controls. Genistein at 5, 15, and 20 μM showed 
a significant increase (p < 0.05) in PTEN compared to its control. While PTEN levels in the 
kaempferol-treated samples also increased significantly (p < 0.05) for each dose at 5 to 25 
μM compared to its control, that of quercetin did not have an effect on PTEN but showed a 
significant decrease (p < 0.05) only at the highest dose of 25 μM. Thus, with regard to 
potency in altering PTEN levels, genistein showed the best effect in increasing PTEN levels 
(Figure 1).
Effects of the flavonoids on breast cancer cells (BT549)
As observed for the A549 cells (Figure 1) there was general increase in PTEN levels for 
genistein and quercetin for the tested doses compared to their respective controls. 
Kaempferol at 5 μM showed a significant decrease (p < 0.05) in PTEN and thereafter 
remained the same for all the other doses compared to its control. At the 5- and 15-μM dose 
levels, quercetin and genistein respectively showed significant (p < 0.05) increases in PTEN 
levels compared to their respective controls. As observed for the lung cancer A549 cell lines 
(Figure 1), kaempferol did not have any effect on PTEN levels except at the 15-μM dose 
(Figure 2).
Effects of the flavonoids on human embryonic kidney cells (HEK293)
Figure 3 shows the PTEN levels in HEK293 cells following exposure to the flavonoids at the 
various doses tested. As observed for the BT459 cell lines (Figure 2), quercetin and 
genistein at the respective doses of 5 and 15 μM showed significant (p < 0.05) increases in 
PTEN levels compared to their respective controls. Again, and as observed for the A549 and 
BT549 cell lines (Figures 1 and 2), kaempferol did not have any effect on PTEN levels at the 
tested doses (Figure 3). With regard to A549 and BT549 cell (Figures 1 and 2) where 
genistein and kaempferol had significant increases at the lower doses of 5 to 15 μM, the 
opposite effect was observed for A549 at the highest doses of 20 and 25 μM.
Effect of the flavonoids on lipid peroxides in PBMCs in donors without and with oxidative 
stress
Effect of genistein on lipid peroxides in PBMCs without and with oxidative 
stress—Figures 4 and 5 respectively show the effects of exposure of genistein on lipid 
peroxides in PBMCs from three independent donors (F1, F2, and F3) without and with 
oxidative stress. The results in Figure 4 indicate that lipid peroxides among the donors 
varied differently and depended on the individual donor. Compared to each donor’s 
respective control, there were no significant differences in lipid peroxides for the doses 
tested except for donor F2, where a significant (p < 0.05) drop in lipid peroxides were 
observed at the 25-μM dose. Lipid peroxides in PBMCs exposed to oxidative stress and the 
flavonoids (Figure 5) compared to those exposed only to the flavonoids (Figure 4) increased 
significantly (p < 0.05) for all the doses tested as analyzed by two-way ANOVA. Again, 
lipid peroxides for the oxidative stressed PBMCs were not significantly different for each of 
the donors compared to their respective controls (Figure 5).
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Effect of kaempferol on lipid peroxides in PBMCs without and with oxidative 
stress—Figures 6 and 7 show the respective profiles of lipid peroxides in PBMCs for three 
independent donors (F4, F5, and F6) treated with kaempferol only and with kaempferol in 
the presence of oxidative stress. Lipid peroxides (Figure 6) increased significantly (p < 0.05) 
for donor F5 at the 5- and 10-μM doses respectively compared to the control. At the 15-μM 
dose for the same donor, however, lipid peroxide decreased significantly (p < 0.01) 
compared respectively to its control and those of the 5- and 10-μM levels. Peroxide levels 
(Figure 7) were significantly higher (p < 0.05) as previously observed for genistein (see 
Figures 4 and 5) in comparison to PBMCs from donors exposed only to kaempferol (Figure 
6). Increases in lipid peroxides were observed in PBMCs from donor F4 at the 15- and 25- 
and F6 at the 5-, 20-, and 25-μM respective doses (Figure 7).
Effect of quercetin on lipid peroxides in PBMCs without and with oxidative 
stress—The effects of quercetin on lipid peroxides in three independent donors (F7, F8, 
and F9) following exposure to flavonoids only and in the presence of the flavonoid following 
oxidative stress are shown in Figures 8 and 9, respectively. Again, as observed for genistein 
and kaempferol, lipid peroxides were variable from donor to donor. Significant decreases (p 
< 0.01) in lipid peroxides were observed for donor F7 at each of the doses from 10 to 25 μM 
compared to its control (Figure 8). However, for donor F8, a significant increase in lipid 
peroxide compared to its control was observed for the 20 and 25 μM, respectively. A 
significant decrease (p < 0.05) in lipid peroxide was observed for donor F9 at 10 μM 
compared to its control (Figure 8). Following exposure to quercetin and in the presence of 
oxidative damage (Figure 9), lipid peroxides remained the same and not significantly 
different for donors F7 and F8 for all the doses tested compared to their respective controls. 
Surprisingly, significant increases (p < 0.05) in lipid peroxides for donor F8 was observed 
for quercetin tested at each of the 10 to 25 μM levels and in the presence of oxidative stress. 
Generally, lipid peroxides were lower for the quercetin-only treated samples (Figure 8) 
compared to those both exposed to quercetin and in the presence of oxidative stress (Figure 
9).
Discussion
Flavonoids, a family of polyphenols, are generally found in various fruits and vegetables, as 
well as in many plant beverages such as tea, pomegranate juice, raspberries, blueberries, and 
red wine (16). Studies on flavonoids have attracted scientific attention as a potential 
nutritional strategy to prevent a broad range of chronic disorders. For example, the 
consumption of these flavonoids in sufficient amounts play neuroprotective, 
cardioprotective, anti-inflammatory, and chemopreventive roles (16, 17). While there has 
been a major focus on the antioxidant properties, there is an emerging view that flavonoids 
and their in vivo metabolites do not act only as conventional antioxidants but may also exert 
modulatory actions on cellular system through direct action on various signaling pathways 
(18). These pathways include phosphoinositide 3-kinase, Akt/protein kinase B, mitogen-
activated protein kinase, tyrosine kinases, and protein kinase C. The inhibitory or 
stimulatory actions of flavonoids on these pathways greatly affect cellular functions by 
altering the phosphorylation state of targeted molecules (18).
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In the present study, we further sought to investigate the effects of exposure of genistein, 
kaempferol, and quercetin on the levels of PTEN in several human cells. In addition, we 
investigated the effects of the above flavonoids on lipid peroxides in PBMCs before and 
after exposure to oxidative stress as described by the Fenton’s chemistry (19). The primary 
hypotheses were (1) that exposure of human cells to genistein, kaempferol, and quercetin 
can increase PTEN levels in those cells to better cope with oxidative stress and (2) that the 
flavonoids might help individuals better cope with oxidative damage by reducing the levels 
of lipid peroxides in PBMCs. The proposed studies represent an effort to define how 
genistein, kaempferol, and quercetin modulate the levels of PTEN, a tumor suppressor gene, 
in breast and lung cancer and human embryonic kidney cells as well as the levels of 
oxidation in PBMC from several donors.
The results in the current studies indicate that genistein, quercetin and, to a lesser extent, 
kaempferol seem to cause significant increases in the levels of PTEN in all the cancer and 
the human embryonic kidney cells, suggesting the potency of such compounds in 
modulating cell growth and probably enhancing cell programmed death. In fact, it has been 
reported elsewhere that the soy phytoestrogens, genistein, daidzein, and equol, not only 
controlled cell-cycle arrest and cell growth inhibition but induced apoptosis or programmed 
cell death in prostate cancer cell apoptosis (20–23). We have previously observed decreases 
in Akt levels in 3T3-L1 preadipocytes following exposure to genistein and quercetin and the 
observed effects were attributed to the down-regulation of the Akt transcription factor (14) 
or low expression of NF-κB (24–26). Thus, the increased PTEN levels attributed by 
genistein and quercetin may be indirectly be due to decreased Akt levels in those cells as we 
have previously reported (14). The differences between quercetin and genistein may indicate 
that quercetin is able to directly curb the PI3K/Akt/IKKα/NF-κB in the cell lines leading to 
the induction of cell apoptosis through a mitochondria-dependent mechanism. In fact, a 
similar observation was seen in human salivary adenoid cystic carcinoma as previously 
observed by Sun et al. (27) and as we have recently reported (14). Furthermore, many other 
reports indicate that flavonoids, including quercetin, are inhibitors of different PI3K 
isoforms and PI3K/Akt axis (28–30), making PI3K a possible molecular target for quercetin. 
The fact is that quercetin is able to inhibit many other kinases and enzymes besides PI3K 
and NF-κB-1, which makes it plausible to assume that the effectiveness also of quercetin in 
comparison to genistein and kaempferol may be due to the multiple facets of quercetin 
targeting several isoforms of the P13K isoforms. Third, the flavonol may act positively on 
the kinase/suppressor factors, thus inducing indirect kinase inhibition. Furthermore, 
quercetin is a strong DNA binder, as reported by Janjua et al. (31), and may be beneficial to 
both individuals who are either genetically or not predisposed to cancer as a result of the 
increases in the levels of PTEN. We have also shown, for the first time and among all the 
tested flavonoids, that the effect of the various doses of kaempferol on the human cells on 
the PTEN levels may be cell line-specific and could be due to the disruption of Tumor 
necrosis factor (TNF)-mediated operations, as has been reported elsewhere (32) or the 
ability of kaempferol to dramatically lower the production of reactive oxygen species in 
HEK293 cells (32) and, ostensibly, significantly handicapping the TNF assembly in addition 
to its broad spectrum of inflammatory effects. Our findings are in agreement in similar 
studies where HEK 293 cells, when exposed to kaempferol, blocked not only TNF-induced 
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Interleukin-8 (IL-8) promoter activation but also IL-8 gene expression, which has been 
found to be a potent enhancer of angiogenesis as well, once again displaying the wide 
variety of proteins kaempferol affects (33). In summary, increased PTEN levels following 
flavonoid exposure may indicate low oxidative damage, as we have previously demonstrated 
in 3T3-L1 preadipocytes and the cells investigated in the current studies.
To demonstrate the effectiveness of the flavonoids on lipid peroxides before and during the 
oxidative stress processes we have used PBMCs to characterize this phenomena. These cells 
were selected because they seem to reflect hepatic regulation of cholesterol metabolism (10) 
and can migrate through the blood circulation and infiltrate various tissues such as the 
endothelium and adipose tissue (11). In addition, PBMC gene expression might reflect the 
metabolic and immune responses of adipocytes or hepatocytes (11) as well as their 
responses to dietary modifications and drugs at the level of gene expression (12, 13). 
Furthermore, the cells are convenient to use because they can be easily and repeatedly 
collected in sufficient quantities, in contrast to adipose, muscle, and liver tissues. We have 
consistently observed decreases in lipid peroxides in PBMCs from donors exposed only to 
the flavonoids and incubated for 24 hours. Such observations seem to suggest that increasing 
the antioxidant potential of donor cells helps not only to reduce oxidation processes in those 
individuals but may also help those cells better cope during inflammatory and/or oxidative 
stress. Such findings seem to be in agreement with studies by other authors where 
consumption of virgin olive oil (VOO) rich in phenolic compounds and high in 
monounsaturated fatty acids seem to have healthy benefits in humans with disease risk 
factors (34). Similarly, and in other studies, the authors explored the mechanisms of the 
beneficial effects of VOO, a major component of a Mediterranean diet, on gene expression 
at the mRNA levels in PBMCs (35). In that study, the addition of 25 ml per day of VOO up-
regulated not only genes involved in the DNA repairing system, antiapoptotic genes, but 
those genes involved in antioxidant and oxidative cell defense mechanisms (34). Thus, it is 
very plausible to suggest that a diet loaded with high antioxidant potential such as the 
flavonoids could help reverse some potential damage(s) to cell function and viability. As to 
why lipid peroxides increased in PBMCs exposed to the flavonoids and then subjected to 
oxidative damage is very interesting. This is the very first observation of such a phenomenon 
and could either mean that the levels of the flavonoids exposed to the PBMCs may not be 
sufficiently adequate or there is a critical concentration needed by each donor to help those 
individuals better cope with oxidative stress and cell damage. This phenomenon is contrary 
to our previous studies, where we observed reduced lipid peroxides by flavonoids (36), 
suggesting the need to further investigate the critical doses of the flavonoids that are needed 
by the donors to offset any possible damage. Nevertheless, it is of interest to note that the 
elucidation of the mechanisms of the flavonoid antioxidant capacity on health and how much 
these benefits are related to reduce oxidative stress may depend on the donor. We also wish 
to state that the use of PBMCs in the current study is not an intervention study in which 
dietary manipulation was done by means of supplementation with the flavonoids since we 
did not have all the relevant information on the donors with regard to background in terms of 
dietary intake. The authors are suggesting that the above studies might be considered as a 
proof of concept to demonstrate the beneficial effects of these flavonoids and their impacts 
on the inflammatory process.
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The variability in the lipid peroxide data also seems to suggest that individual differences 
both genetically and environmentally may dictate the critical levels of antioxidants for each 
individual, family, or population (19) and/or may be due to our inability to access full 
biographical data (due to confidentiality and compliance issues by the American Red Cross) 
regarding their age, sex, lifestyle, and diet. The availability of such information could have 
helped to normalize the data to their respective age, sex, and life-style for proper 
interpretation of the data on the potency of the flavonoids. Nevertheless, and taken together, 
our findings provide important insights into the mechanisms underlying the anti-obesity 
activity of the flavonoids and may be mediated by the inhibition of Akt activation by the 
decreased phosphorylation, which may induce the down-regulation of lipid accumulation 
and lipid metabolizing genes as observed previously (14) and the concomitant increases in 
PTEN as we have observed in the current study.
Conclusions
Our findings seem to suggest that the flavonoids are capable of enhancing the antioxidant 
levels by increasing PTEN levels in several human cells to better cope with oxidative 
damage. Second, individual differences in donor profiles may or may not truly reflect the 
potential benefits of such compounds in one’s diet. However, the findings from the current 
studies seem to suggest that consumption of foods containing polyphenols may help reduce 
the causes of factors related to the metabolic syndrome (37–39) and those associated with 
the anti-inflammatory mechanisms and improved antioxidant capacity (40, 41). Finally, the 
increased activity of PTEN as we have observed in the current study could help explain the 
concomitant low expression levels for both the phospho- and total-Akt gene (14), further 
substantiating the inverse relationship between the expression levels of Akt and PTEN gene 
as we and others have observed (14).
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The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and 
quercetin on phospho tensin homolog (PTEN) in lung cancer cell line, A549, following 
incubation at 37 °C and 5% CO2 for 24 h. Each bar chart for each flavonoid ± standard 
deviation in this and Figures 2 and 3 in this article represent mean for three different 
experiments for each dose level of genistein, kaempferol, and quercetin tested and which 
was assayed in triplicates. Statistical significances denoted by asterisks in Figures 1 through 
3 are shown as comparison between the respective control (i.e., without genistein, 
kaempferol, and quercetin) and genistein, kaempferol, and quercetin A549 cells treated 
subgroups. *p < 0.05. Vertical bars in this and other figures denote standard deviation. The 
X-axis labels for Figures 1 through 3 are defined as follows: 0 means control cell samples 
not treated with genistein, kaempferol, and quercetin; 5, 10, 15, 20, and 25 μM means cell 
samples were each treated with the respective dose of genistein, kaempferol, and quercetin 
for 24 hours.
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The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and 
quercetin on phospho tensin homolog (PTEN) in breast cancer cell line, BT549, following 
incubation at 37 °C and 5% CO2 for 24 hours. For comparison and statistical differences, see 
Figure 1.
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The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and 
quercetin on phospho tensin homolog (PTEN) in human embryonic cells, HEK293, 
following incubation at 37 °C and 5% CO2 for 24 hours. For comparison and statistical 
differences, see Figure 1.
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The effects of several doses of genistein (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F1, F2, 
and F3) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for 
24 hours. Statistical significances denoted by asterisk in Figures 4 through 9 are shown as 
comparison between the respective control (i.e., without genistein, kaempferol, or quercetin) 
and with genistein, kaempferol, or quercetin PBMCs cells treated subgroups without 
oxidative damage.. For comparison and statistical differences, see Figure 1.
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The effects of several doses of genistein (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F1, F2, 
and F3) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and 
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.
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The effects of several doses of kaempferol (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F4, F5, 
and F6) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for 
24 hours. For comparison and statistical differences, see Figure 4.
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The effects of several doses of kaempferol (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F4, F5, 
and F6) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and 
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.
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The effects of several doses of quercetin (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F7, F8, 
and F9) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for 
24 hours. For comparison and statistical differences, see Figure 4.
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The effects of several doses of quercetin (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in 
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F7, F8, 
and F9) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and 
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.
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